Next, in accordance with the results obtained in protein array analyses, CCL16 and sTNF-RII levels were significantly increased in plasma of fast ALS (13.01 ng/mL) as compared to slow ALS (9.994 ng/mL) (p = 0.0204) (Figure 3c) and (3.093 ng/mL vs. 2.563 ng/mL) (p = 0.0464) (Figure 3d), respectively. This evidence concerns the gene CCL16 and amyotrophic lateral sclerosis.